Evidence map›Paper›PMID 31165870›Full record

ArticleNucleic acids research2019

Enzyme-free optical DNA mapping of the human genome using competitive binding.

Vilhelm Müller, Albertas Dvirnas, John Andersson, Vandana Singh, Sriram Kk, Pegah Johansson, Yuval Ebenstein, Tobias Ambjörnsson, Fredrik Westerlund

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Strain-Level Typing ofACS infectious diseases · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Vilhelm MüllerDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Albertas DvirnasDepartment of Astronomy and Theoretical Physics, Lund University, Lund, Sweden.
John AnderssonDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Vandana SinghDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Sriram KkDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Pegah JohanssonClinical Chemistry, Sahlgrenska University Hospital, Gothenburg, Sweden.
Yuval EbensteinSchool of Chemistry, Center for Nanoscience and Nanotechnology, Center for Light-Matter Interaction, Raymond and Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, Tel Aviv, Israel.
Tobias AmbjörnssonDepartment of Astronomy and Theoretical Physics, Lund University, Lund, Sweden.
Fredrik WesterlundDepartment of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.
Chalmers University of Technology · SELund University · SESahlgrenska University Hospital · SETel Aviv University · IL

Funding

Co-detection of DNA adducts and methylation sites as predictive biomarkers for exposuresR21ES028015 · NIEHS · UNIVERSITY OF SOUTH ALABAMA · PI EBENSTEIN, YUVAL, GASSMAN, NATALIE ROSE · 2017 to 2018
$389k
NIEHS NIH HHS R21 ES028015
6 · The paper itself

Abstract

Optical DNA mapping (ODM) allows visualization of long-range sequence information along single DNA molecules. The data can for example be used for detecting long range structural variations, for aiding DNA sequence assembly of complex genomes and for mapping epigenetic marks and DNA damage across the genome. ODM traditionally utilizes sequence specific marks based on nicking enzymes, combined with a DNA stain, YOYO-1, for detection of the DNA contour. Here we use a competitive binding approach, based on YOYO-1 and netropsin, which highlights the contour of the DNA molecules, while simultaneously creating a continuous sequence specific pattern, based on the AT/GC variation along the detected molecule. We demonstrate and validate competitive-binding-based ODM using bacterial artificial chromosomes (BACs) derived from the human genome and then turn to DNA extracted from white blood cells. We generalize our findings with in-silico simulations that show that we can map a vast majority of the human genome. Finally, we demonstrate the possibility of combining competitive binding with enzymatic labeling by mapping DNA damage sites induced by the cytotoxic drug etoposide to the human genome. Overall, we demonstrate that competitive-binding-based ODM has the potential to be used both as a standalone assay for studies of the human genome, as well as in combination with enzymatic approaches, some of which are already commercialized.

Indexed as

Genome, HumanAntineoplastic Agents, PhytogenicBenzoxazolesBinding, CompetitiveBinding SitesChromosome MappingChromosomes, Artificial, BacterialDNAEtoposideFluorescent DyesHumansLeukocytes, MononuclearNetropsinQuinolinium CompoundsSequence Analysis, DNASingle Molecule Imaging1,1'-((4,4,7,7-tetramethyl)-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-oxazole)-2-methylidene)quinoliniumAntineoplastic Agents, PhytogenicBenzoxazolesDNAEtoposideFluorescent DyesNetropsinQuinolinium Compounds

Identifiers

PMID31165870
PMCPMC6735870
OpenAlexW2968947783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.